Finance

Lists
PHARMA:KLSE
Pharmaniaga Bhd
0,86 MYR
+1,76%
(+0,015) 1D
13 ოქტ, 17:00:00 GMT+8  ·   MYR
All symbols
SymbolPriceChange% Change
Generating top insights for PHARMA...
Open
0,84 MYR
High
0,87 MYR
Low
0,83 MYR
Mkt. cap
1,13 მლრდ.
Avg. vol.
2,31 მლნ.
Volume
1,44 მლნ.
Dividend
2,00%
Quarterly dividend
0,00 MYR
Ex-dividend date
14 სექ. 2026
P/E ratio
16,24
52-wk high
1,70 MYR
52-wk low
0,83 MYR
EPS
0,05 MYR
Shares outstanding
1,31 მლრდ.
No. of employees
4 ათ.
Open
0,84 MYR
High
0,87 MYR
Low
0,83 MYR
Mkt. cap
1,13 მლრდ.
Avg. vol.
2,31 მლნ.
Volume
1,44 მლნ.
Dividend
2,00%
Quarterly dividend
0,00 MYR
Ex-dividend date
14 სექ. 2026
P/E ratio
16,24
52-wk high
1,70 MYR
52-wk low
0,83 MYR
EPS
0,05 MYR
Shares outstanding
1,31 მლრდ.
No. of employees
4 ათ.
News stories
From web sources and news partners
Profile
Pharmaniaga Berhad is Malaysia’s largest listed integrated healthcare company, offering research and development, manufacturing, logistics, and distribution of pharmaceuticals and medical supplies. Wikipedia
About Pharmaniaga Bhd
CEOZulkarnain Md Eusope
Employees3,5 ათ.
Founded1994
Headquarters-
SectorHealth care provider
Websitepharmaniaga.com
Previous reportsAll values in MYR
Loading Previous Earnings...
Revenue
Net income
All values in MYR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
1,01 მლრდ.
938,28 მლნ.
1,18 მლრდ.
1,04 მლრდ.
Cost of goods sold
911,96 მლნ.
841,28 მლნ.
1,05 მლრდ.
939,04 მლნ.
Cost of revenue
911,96 მლნ.
841,28 მლნ.
1,05 მლრდ.
939,04 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
73,17 მლნ.
48,05 მლნ.
73,51 მლნ.
75,89 მლნ.
Operating expense
73,17 მლნ.
73,67 მლნ.
73,51 მლნ.
75,89 მლნ.
Total operating expenses
985,13 მლნ.
914,96 მლნ.
1,12 მლრდ.
1,01 მლრდ.
Operating income
22,13 მლნ.
23,32 მლნ.
55,02 მლნ.
26,10 მლნ.
Other non operating income
482,00 ათ.
-2,18 მლნ.
92,00 ათ.
107,00 ათ.
EBT including unusual items
10,36 მლნ.
11,44 მლნ.
46,41 მლნ.
17,81 მლნ.
EBT excluding unusual items
10,36 მლნ.
11,18 მლნ.
46,41 მლნ.
17,81 მლნ.
Income tax expense
2,87 მლნ.
2,71 მლნ.
14,22 მლნ.
4,78 მლნ.
Effective tax rate
27,67%
23,69%
30,64%
26,87%
Other operating expenses
-
-
-
-
Net income
7,28 მლნ.
7,70 მლნ.
31,47 მლნ.
12,49 მლნ.
Net profit margin
0,72%
0,82%
2,67%
1,20%
Earnings per share
-
-
-
-
Interest and investment income
2,39 მლნ.
2,20 მლნ.
1,38 მლნ.
1,79 მლნ.
Interest expense
-14,65 მლნ.
-12,17 მლნ.
-10,08 მლნ.
-10,19 მლნ.
Net interest expenses
-12,26 მლნ.
-9,96 მლნ.
-8,70 მლნ.
-8,40 მლნ.
Depreciation and amortization charges
-
19,12 მლნ.
-
-
EBITDA
30,71 მლნ.
30,81 მლნ.
64,67 მლნ.
32,51 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები